Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy

By sjmartinez • May 11, 2024

Kittipibul V, Vaduganathan M, Ikeaba U, Chiswell K, Butler J, DeVore AD, Heidenreich PA, Huang JC, Kittleson MM, Joynt Maddox KE, Linganathan KK, McDermott JJ, Owens AT, Peterson PN, Solomon SD, Vardeny O, Yancy CW, Fonarow GC, Greene SJ. Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy. JACC Heart Fail. 2024 Apr 6:S2213-1779(24)00268-3. doi: 10.1016/j.jchf.2024.04.003. Epub ahead of print. PMID: 38727651.

Tags: Cardiology/Epi, Cost, heart failure, Hospitalization, Publications, SGLT2 inhibitor

Cardiac Sympathetic Innervation and Ventricular Arrhythmias in Structural Heart Disease: Current Peripheral Neuromodulation Therapies and Emerging Therapeutic Targets

Benabou L, Vaseghi M. Cardiac Sympathetic Innervation and Ventricular Arrhythmias in Structural Heart Disease: Current Peripheral Neuromodulation Therapies and Emerging Therapeutic Targets. Arrhythm Electrophysiol Rev.[...]

Hyperaldosteronism Presenting as Pre-syncope: A Case Report

Mazar M, Tabibiazar R, Dave R. Hyperaldosteronism Presenting as Pre-syncope: A Case Report. Cureus. 2025 Dec 8;17(12):e98735. doi: 10.7759/cureus.98735. PMID: 41510441; PMCID: PMC12778885.

Real World Genetic Testing Practices in Cardiomyopathy: National insights from 1.7 million patients

Bui QM, Morales A, Adler ED, Urey MA, Sinha A, Wang J, Hong KN, Ramsis M. Real World Genetic Testing Practices in Cardiomyopathy: National insights[...]